Pfizer and BioNTech SE Submit Data on Covid Vaccine for Kids 5-11 to FDA; Emergency Use Authorization Could Come By Halloween

The pharmaceutical companies are confident they’re one step closer to making vaccination an option for millions of younger children.

Leave a comment

Your email address will not be published. Required fields are marked *